16 March 2014
A team from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer’s disease.
18 February 2014
Researchers studying peptides using the Gordon supercomputer at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego (UCSD) have found new ways to elucidate the creation of the toxic oligomers associated with Alzheimer’s disease.
18 February 2014
Neuropsychological assessment more efficient than MRI for tracking disease progression in memory clinic patients
Amsterdam, NL – Investigators at the University of Amsterdam, The Netherlands, have shown that progression of disease in memory clinic patients can be tracked efficiently with 45 minutes of neuropsychological testing.
7 February 2014
After the successful launch of sister publications the Journal of Parkinson’s Disease and the Journal of Huntington’s Disease, JAD is delighted to announce the forthcoming launch of the Journal of Neuromuscular Diseases (JND).
18 December 2013
Australian researchers have identified lifestyle factors that impair women’s brain performance as early as age 45.A joint study from The University of Queensland, the University of New South Wales and Flinders University of South Australia shows certain lifestyle behaviours like smoking, excessiv
4 December 2013
Stony Brook, NY–A team of Stony Brook University researchers led by William Van Nostrand, PhD, Professor in the Department of Neurosurgery, has discovered in a model of Alzheimer’s disease that early accumulation of a small protein, known as amyloid-β, in the blood vessels of the brain can drive
2 December 2013
Montreal – At the first signs of memory loss, most people start worrying and wonder, “What if I have Alzheimer's disease?” And yet, the disease is often diagnosed late in its development and sometimes up to ten years after the first pathological changes have affected the brain.
14 November 2013
Prescription of anti-Alzheimer medications to persons with mild cognitive impairment (MCI) is low in France
In France prescription of drugs for Alzheimer’s disease (AD) is strictly regulated. The Department of Public Health and the Memory Clinic of Nice University Hospital have explored real world prescriptions of anti-AD medications in patients with mild cognitive impairment (MCI) not AD.
7 November 2013
Draws on information from a single patient visit. New York-A Columbia University Medical Center-led research team has clinically validated a new method for predicting time to full-time care, nursing home residence, or death for patients with AD.
5 November 2013
Lexington, KY — As the population of older adults continues to grow, researchers at the University of Kentucky Sanders-Brown Center on Aging are engaged in work to understand the mechanisms of a variety of diseases that predominately affect th